Cyclacel Pharmaceuticals, Inc. (CYCC) Announces Proposed Public Offering of Common Stock
5/16/2013 10:22:10 AM
More...
|
Cyclacel Pharmaceuticals, Inc. (CYCC) Announces $20 Million Underwritten Offering
5/16/2013 9:44:20 AM
More...
|
Cyclacel Pharmaceuticals, Inc. (CYCC) Reports First Quarter 2013 Financial Results
5/14/2013 9:55:03 AM
More...
|
Cyclacel Pharmaceuticals, Inc. (CYCC) to Announce Release of First Quarter 2013 Financial Results
5/10/2013 9:24:22 AM
More...
|
Cyclacel Pharmaceuticals, Inc. (CYCC) Reports Updated Phase 2 Survival Data of Sapacitabine for MDS
4/30/2013 11:48:35 AM
More...
|
Cyclacel Pharmaceuticals, Inc. (CYCC) to Present at the 12th Annual Needham Healthcare Conference
4/23/2013 11:29:00 AM
More...
|
American Association for Cancer Research Press Conference Highlights Combination Potential of Two Cyclacel Pharmaceuticals, Inc. (CYCC) Drugs
4/8/2013 11:26:01 AM
More...
|
Cyclacel Pharmaceuticals, Inc. (CYCC) Selling Patents to Celgene Corporation (CELG) for $5.5 Million
4/4/2013 7:41:13 AM
More...
|
Cyclacel Pharmaceuticals, Inc. (CYCC) to Announce Year-End and Fourth Quarter 2012 Financial Results
3/22/2013 9:53:18 AM
More...
|
Cyclacel Pharmaceuticals, Inc. (CYCC) Reviews 2012 Achievements and Announces Key Business Objectives for 2013
1/7/2013 9:47:43 AM
More...
|
|